Murcko Mark 4
4 · Relay Therapeutics, Inc. · Filed Jun 5, 2024
Insider Transaction Report
Form 4
Murcko Mark
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-03+102,225→ 102,225 totalExercise: $6.79Exp: 2034-06-02→ Common Stock (102,225 underlying)
Footnotes (1)
- [F1]This option was granted on June 3, 2024 with respect to 102,225 shares of the Issuer's common stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the grant date.